RECOGNIZED AS A WORLD LEADER,
ADVANCING PRACTICES IN MEDICINE,
SCIENCE AND TECHNOLOGY.
Out of 3,000 entries, Abbott was selected as the World-Changing Company of the Year for its Piccolo Occluder device for premature babies with holes in their hearts, its work advancing the careers of underrepresented groups in STEM, its role in fighting malaria around the world and its development of COVID-19 tests.
We've been named one of the World's Most Admired Companies by Fortune magazine every year since 1984 and ranked No. 1 in our industry sector for seven consecutive years (2014-2020).
We were named the global healthcare Industry Group Leader for eight consecutive years (2013-2020) for our strong economic, environmental and social performance.
Abbott has been named a Blue Ribbon company in 2021 for its placement on four of Fortune's most prestigious annual rankings: Change the World, Global 500, Fortune 500 and World's Most Admired Companies.
WE STRIVE TO BE RECOGNIZED AS A BEST PLACE TO WORK THROUGHOUT THE WORLD.
We've been included on Science magazine's Top 20 Employers list 17 times, most recently in 2020.
Abbott is certified as a "Great Place to Work" in the U.S. and was also honored by Fortune as one of 18 "best workplaces" with 100,000 or more employees.
We've been named on DiversityInc's list of Top Companies for Diversity for consecutive years, from 2004-2020.
Working Mother magazine has named us a "100 Best Company for 20 years in a row"; the National Association for Female Executives has recognized us as a top company for executive women for 12 years in a row.
WHEN DEVELOPING HEALTHCARE SOLUTIONS FOR PEOPLE AROUND THE GLOBE, WE SET OUR SIGHTS BEYOND OUR REACH.
Abbott has been recognized by Popular Science’s Best of What’s New, The Scientist's Top 10 Innovations for 2020, Chicago Innovation Awards, ChicagoInno's 2020 Inno on Fire and by Fast Company's World-Changing Ideas for its rapid development of COVID-19 tests.
The industry equivalent of the Nobel Prize, Prix Galien honored MitraClip as the Best Medical Technology for 2020.
Chicago Innovation Awards honored revolutionary occluder for helping preemie babies with congenital heart defects.
Continuous glucose monitor named Best Medical Technology as part of Galien Foundation's Prix Galien competition.
WE'RE RECOGNIZED AROUND THE WORLD FOR RESPONSIBLE AND SUSTAINABLE BUSINESS.
3BL Media named us among the top 100 companies for 12 consecutive years (2009-2020), and the healthcare sector leader in 2017.
Fortune magazine included us on their 2020 "Change the World" list, which recognizes companies for delivering shared value by making positive social impacts through their core business.
We were named No. 42 on Fortune's Top 50 Most Admired Companies in 2021 as well as No. 1 in our industry sector for the eighth consecutive year.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.